Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Arch Dis Child ; 94(6): 448-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19224889

ABSTRACT

Ataxia-telangiectasia (A-T) is characterised by progressive neurological abnormalities, oculocutaneous telangiectasias and immunodeficiency (decreased serum IgG subclass and/or IgA levels and lymphopenia). However, 10% of A-T patients present with decreased serum IgG and IgA with normal or raised IgM levels. As cerebellar ataxia and oculocutaneous telangiectasias are not present at very young age, these patients are often erroneously diagnosed as hyper IgM syndrome (HIGM). Eight patients with A-T, showing serum Ig levels suggestive of HIGM on first presentation, are described. All had decreased numbers of T lymphocytes, unusual in HIGM. The diagnosis A-T was confirmed by raised alpha-fetoprotein levels in all patients. To prevent mistaking A-T patients for HIGM it is proposed to add DNA repair disorders as a possible cause of HIGM.


Subject(s)
Ataxia Telangiectasia/immunology , Hyper-IgM Immunodeficiency Syndrome/diagnosis , Immunoglobulin G/analysis , Child , Child, Preschool , DNA Repair , Female , Humans , Hyper-IgM Immunodeficiency Syndrome/immunology , Infant , Lymphocyte Count , Male , T-Lymphocytes/immunology
2.
Leukemia ; 21(2): 230-7, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17170727

ABSTRACT

The BIOMED-2 multiplex polymerase chain reaction (PCR) tubes for analysis of immunoglobulin and T-cell receptor (TCR) gene rearrangements have recently been introduced as a reliable and easy tool for clonality diagnostics in suspected lymphoproliferations. Quality and performance assessment of PCR-based clonality diagnostics is generally performed using human leukemia/lymphoma cell lines as controls. We evaluated the utility of 30 well-defined human T-cell lines for quality performance testing of the BIOMED-2 PCR primers and protocols. The PCR analyses of the TCR loci were backed up by Southern blot analysis. The clonal TCRB, TCRG and TCRD gene rearrangements were analyzed for gene segment usage and for the size and composition of their junctional regions. In 29 out of 30 cell lines, unique clonal TCR gene rearrangements could be easily detected. Besides their usefulness in molecular clonality diagnostics, these cell lines can now be authenticated based on their TCR gene rearrangement profile. This enables their correct use in molecular clonality diagnostics and in other cancer research studies.


Subject(s)
Gene Rearrangement , Polymerase Chain Reaction/methods , Receptors, Antigen, T-Cell/genetics , T-Lymphocytes/immunology , Cell Culture Techniques , Cell Line , Humans , Immunophenotyping
3.
Ned Tijdschr Geneeskd ; 148(21): 1053-6, 2004 May 22.
Article in Dutch | MEDLINE | ID: mdl-15185441

ABSTRACT

X-linked agammaglobulinaemia (XLA) is a primary immunodeficiency caused by a mutation in the gene encoding Bruton's tyrosine kinase (BTK). The classical presentation of XLA consists of the almost complete absence of B-lymphocytes and immunoglobulins in the peripheral blood leading to severe, mainly bacterial, upper and lower respiratory-tract infections already in early childhood. Irrespective of the kind of BTK-gene mutation the phenotype of XLA can be very diverse. Two 9-year-old cousins with the same BTK-gene mutation illustrate this phenotypical diversity. One boy had a classical presentation and was on maintenance treatment with intravenous immunoglobulins and prophylactic antibiotics to control his infections. Without any prophylactic treatment, his cousin had no abnormal infectious course despite very low B-lymphocyte counts and immunoglobulin levels in the blood. The mechanisms underlying the phenotypical diversity of XLA have not been clarified. Gene polymorphisms affecting the innate immune system may play a role.


Subject(s)
Agammaglobulinemia/genetics , Genetic Diseases, X-Linked/genetics , Polymorphism, Genetic , Agammaglobulinemia/blood , Agammaglobulinemia/diagnosis , Child , Child, Preschool , Diagnosis, Differential , Genetic Diseases, X-Linked/blood , Genetic Diseases, X-Linked/diagnosis , Humans , Infant , Male , Phenotype
4.
Eur J Pediatr ; 160(10): 583-91, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11686500

ABSTRACT

From time to time, paediatricians are confronted with children who might suffer from a primary immunodeficiency disease. For practical purposes, these children can be divided into four main clinical categories: (1) a relatively large group of children with recurrent ear-nose and throat and lower respiratory tract infections, in some cases caused by deficiencies of antibodies or complement; (2) children with failure to thrive, intractable diarrhoea or an opportunistic infection which can be caused by a T-lymphocyte or combined immunodeficiency; (3) children with infections with pyogenic bacteria or fungi as seen in case of granulocyte/monocyte function deficiency; and (4) a small heterogeneous group of children with recurrence of particular infections. Also, acquired immunodeficiency becomes a more common problem in paediatric practice. Flow cytometric immunophenotyping of leucocytes appears to be an efficient and rapid tool in the diagnosis and follow-up of immunodeficient patients, supporting early recognition, before serious infections have compromised the child's general condition. This technique can now be performed in many hospitals. In this review, we give directions for the use of flow cytometric immunophenotyping of leucocytes in the diagnosis and follow-up of immunodeficient children according to the four main clinical categories.


Subject(s)
Immunologic Deficiency Syndromes/diagnosis , Immunophenotyping/methods , Child , Child, Preschool , Diarrhea/immunology , Failure to Thrive/immunology , Flow Cytometry/methods , Follow-Up Studies , HIV Infections/immunology , Humans , Immunologic Deficiency Syndromes/classification , Immunologic Deficiency Syndromes/complications , Infant , Opportunistic Infections/immunology , Respiratory Tract Infections/immunology
6.
Eur J Pediatr ; 160(12): 718-25, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11795679

ABSTRACT

UNLABELLED: Omenn syndrome is a form of severe combined immunodeficiency associated with high mortality. Early recognition is required in order to initiate life-saving therapy. This review provides information on the clinical symptoms, laboratory parameters and pathology of the disease, supporting early diagnosis in suspected patients. A literature search was performed using Medline, encompassing the period 1965-1999. Sixty-seven cases were identified and with the addition of a recently diagnosed patient at our hospital, 68 children were included. Median age at onset of symptoms was 4 weeks. Key symptoms were erythematous rash (98%), hepatosplenomegaly (88%), lymphadenopathy (80%), often accompanied by recurrent infections (72%) and alopecia (57%). An elevated WBC (55%) was frequently observed, due to eosinophilia and/or lymphocytosis. B-cell counts were significantly decreased whereas T-cell counts were elevated. A high serum IgE was another frequent finding (91%). Therapeutic options include bone marrow transplantation or cord blood stem cell transplantation; however, the mortality still was 46%. CONCLUSION: Omenn syndrome is a fatal disease if untreated. The mortality may be reduced when diagnosis is established early and treatment is initiated rapidly by using early compatible bone marrow transplantation or cord blood stem cell transplantation.


Subject(s)
Severe Combined Immunodeficiency/diagnosis , Severe Combined Immunodeficiency/therapy , Bone Marrow Transplantation , Female , Fetal Blood/cytology , Hematopoietic Stem Cell Transplantation , Humans , Infant , Infant, Newborn , Male , Practice Guidelines as Topic , Severe Combined Immunodeficiency/immunology , Severe Combined Immunodeficiency/mortality , Treatment Outcome
7.
Blood ; 96(1): 203-9, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10891452

ABSTRACT

The proteins encoded by RAG1 and RAG2 can initiate gene recombination by site-specific cleavage of DNA in immunoglobulin and T-cell receptor (TCR) loci. We identified a new homozygous RAG1 gene mutation (631delT) that leads to a premature stop codon in the 5' part of the RAG1 gene. The patient carrying this 631delT RAG1 gene mutation died at the age of 5 weeks from an Omenn syndrome-like T(+)/B(- )severe combined immunodeficiency disease. The high number of blood T-lymphocytes (55 x 10(6)/mL) showed an almost polyclonal TCR gene rearrangement repertoire not of maternal origin. In contrast, B-lymphocytes and immunoglobulin gene rearrangements were hardly detectable. We showed that the 631delT RAG1 gene can give rise to an N-terminal truncated RAG1 protein, using an internal AUG codon as the translation start site. Consistent with the V(D)J recombination in T cells, this N-terminal truncated RAG1 protein was active in a plasmid V(D)J recombination assay. Apparently, the N-terminal truncated RAG1 protein can recombine TCR genes but not immunoglobulin genes. We conclude that the N-terminus of the RAG1 protein is specifically involved in immunoglobulin gene rearrangements.


Subject(s)
Gene Rearrangement, T-Lymphocyte , Gene Rearrangement , Genes, Immunoglobulin , Genes, RAG-1 , Homeodomain Proteins/genetics , Homeodomain Proteins/immunology , Immunologic Deficiency Syndromes/genetics , T-Lymphocytes/immunology , B-Lymphocytes/immunology , Codon, Terminator , Consanguinity , Fatal Outcome , Female , Homozygote , Humans , Immunologic Deficiency Syndromes/immunology , Immunophenotyping , Infant, Newborn , Male , Sequence Deletion
9.
Nucleic Acids Res ; 26(1): 242-7, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9399844

ABSTRACT

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations has been compiled and the recent update lists 463 mutation entries from 406 unrelated families showing 303 unique molecular events. In addition to mutations, the database also lists variants or polymorphisms. Each patient is given a unique patient identity number (PIN). Information is included regarding the phenotype including symptoms. Mutations in all the five domains of BTK have been noticed to cause the disease, the most common event being missense mutations. The mutations appear almost uniformly throughout the molecule and frequently affect CpG sites that code for arginine residues. The putative structural implications of all the missense mutations are given in the database. The improved version of the registry having a number of new features is available at http://www. helsinki.fi/science/signal/btkbase.html


Subject(s)
Agammaglobulinemia/genetics , Databases, Factual , Mutation , Protein-Tyrosine Kinases/genetics , X Chromosome , Agammaglobulinaemia Tyrosine Kinase , Amino Acid Sequence , Computer Communication Networks , Humans , Information Storage and Retrieval , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL
...